BionaFem Side Effects & Health Impacts

Low folate status contributes to elevated homocysteine, a metabolite that has been associated with endothelial dysfunction, arterial stiffness, and a higher risk of stroke and coronary heart disease. Large observational studies consistently show that individuals with higher homocysteine levels have greater rates of cardiovascular events, and folate intake is one of the key nutritional determinants of homocysteine. Clinically, folic acid supplementation (often combined with vitamins B6 and B12) can lower homocysteine and appears to modestly reduce stroke risk in some populations, making the identification and correction of folate deficiency an important part of broader cardiovascular risk reduction.

Research: Yanping Li, et al. Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta‐Analysis of Randomized Controlled Trials. Journal of the American Heart Association. Volume 5, Number 8. August 15 2016.Yi X, Zhou Y, Jiang D, Li X, Guo Y, Jiang X. Efficacy of folic acid supplementation on endothelial function and plasma homocysteine concentration in coronary artery disease: A meta-analysis of randomized controlled trials. Exp Ther Med. 2014 May;7(5):1100-1110. Kaye AD, Jeha GM, Pham AD, Fuller MC, Lerner ZI, Sibley GT, Cornett EM, Urits I, Viswanath O, Kevil CG. Folic Acid Supplementation in Patients with Elevated Homocysteine Levels. Adv Ther. 2020 Oct;37(10):4149-4164. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006 Apr 13;354(15):1567-77. Wald DS, Bishop L, Wald NJ, et al. Randomized Trial of Folic Acid Supplementation and Serum Homocysteine Levels. Arch Intern Med. 2001;161(5):695–700.

Folate deficiency in the periconceptional period significantly increases the risk of neural tube defects (NTDs) such as spina bifida and anencephaly, because adequate folate is required for proper closure of the embryonic neural tube in the first month of pregnancy. Large observational datasets and randomized trials have shown that appropriate folic acid supplementation before conception and in early pregnancy can reduce NTD risk by roughly 50–70% in the general population, with even greater risk reduction in women with a prior NTD‑affected pregnancy. The practical implication is that all women of childbearing potential, not just those actively planning pregnancy, are typically advised to maintain adequate daily folic acid intake so that red‑cell folate stores are sufficient well before conception occurs.

Research: Viswanathan M, Urrutia RP, Hudson KN, Middleton JC, Kahwati LC. Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2023;330(5):460–466. Wald NJ. Folic acid and neural tube defects: Discovery, debate and the need for policy change. J Med Screen. 2022 Sep;29(3):138-146. Mathieu d'Argent E, Ravel C, Rousseau A, Morcel K, Massin N, Sussfeld J, Simon T, Antoine JM, Mandelbaume J, Daraï E, Kolanska K. High-Dose Supplementation of Folic Acid in Infertile Men Improves IVF-ICSI Outcomes: A Randomized Controlled Trial (FOLFIV Trial). J Clin Med. 2021 Apr 26;10(9):1876. Jadhav, S. N., & Pitale, D. L. (2020). Effectiveness of folic acid in unexplained infertility. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 9(9), 3780–3783.

In susceptible adults, acute thiamine (vitamin B1) deficiency can rapidly trigger an encephalopathy marked by confusion, gait ataxia, and ocular motor abnormalities such as nystagmus or ophthalmoplegia. This classic triad is often incomplete at presentation, and only a minority of patients show all three features together initially, which contributes to delayed diagnosis. Because body stores are quickly exhausted, maintaining adequate ongoing thiamine intake is critical, and can reverse many of the acute neurologic signs if started early, whereas even short delays increase the risk of persistent cognitive impairment and structural brain injury on imaging.

Research: Yin H, Xu Q, Cao Y, Qi Y, Yu T, Lu W. Nonalcoholic Wernicke's encephalopathy: a retrospective study of 17 cases. J Int Med Res. 2019 Oct;47(10):4886-4894. Isenberg-Grzeda E, Alici Y, Hatzoglou V, Nelson C, Breitbart W. Nonalcoholic Thiamine-Related Encephalopathy (Wernicke-Korsakoff Syndrome) Among Inpatients With Cancer: A Series of 18 Cases. Psychosomatics. 2016 Jan-Feb;57(1):71-81. Clark AF. Use of Thiamine Supplementation in Pregnant Women Diagnosed With Hyperemesis Gravidarum and Wernicke Encephalopathy. Nurs Womens Health. 2024 Jun;28(3):222-226. Bento MA, Vieira JB, Silva ML and Camolas J (2024) Case report: Wernicke–Korsakoff syndrome after bariatric surgery. Front. Nutr. 10:1321275.

In older adults, low folate status has been associated with a higher risk of mild cognitive impairment (MCI) and faster cognitive decline over time, likely through effects on one‑carbon metabolism and homocysteine. Several longitudinal cohort studies have found that individuals with lower serum or red‑cell folate and higher homocysteine show steeper declines on memory and global cognition tests, and in some cohorts have a significantly higher incidence of MCI or dementia over follow‑up. The clinically important takeaway is that, when folate deficiency is detected and corrected (usually along with ensuring adequate vitamin B12), some patients demonstrate stabilization or modest improvement in cognitive performance, particularly when interventions are combined with aggressive management of vascular risk factors such as hypertension and diabetes.

Research: Ma, F., Wu, T., Zhao, J. et al. Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI. Sci Rep 6, 37486 (2016). Wang M, Fang M, Zang W. Effects of folic acid supplementation on cognitive function and inflammation in elderly patients with mild cognitive impairment: A systematic review and meta-analysis of randomized controlled trials. Arch Gerontol Geriatr. 2024 Nov;126:105540. O’Connor, D.M.A., Scarlett, S., De Looze, C. et al. Low folate predicts accelerated cognitive decline: 8-year follow-up of 3140 older adults in Ireland. Eur J Clin Nutr 76, 950–957 (2022).Putu Eka Widyadharma. Folic acid supplementation improves cognitive function: A systematic review. December 2020 Romanian Journal of Neurology 19(4):219-223.

Low zinc status has been linked to a higher risk and faster progression of age-related macular degeneration (AMD), in part because zinc is concentrated in the retina and supports antioxidant defenses there. In the landmark AREDS trial, a supplement formula containing zinc (80 mg as zinc oxide), along with antioxidants, reduced the risk of progression to advanced AMD by about 25% in people with intermediate disease or advanced disease in one eye over roughly 5 years. Other research has shown that inadequate zinc intake is more common in older adults with AMD, reinforcing the idea that maintaining healthy zinc levels may be an important, and often overlooked, strategy for preserving macular health with age.

Research: Smailhodzic D, van Asten F, Blom AM, Mohlin FC, den Hollander AI, van de Ven JPH, et al. (2014) Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration. PLoS ONE 9(11): e112682. Lengyel D, Török B. Erworbene vorübergehende Nachtblindheit bei Vitamin-A- und Zinkmangel bei Anorexia nervosa neun Jahre nach Nierentransplantation [Acquired temporary night blindness in vitamin A and zinc deficiency in anorexia nervosa nine years after kidney transplantation]. Klin Monbl Augenheilkd. 2006 May;223(5):453-5. German.Blasiak J, Pawlowska E, Chojnacki J, Szczepanska J, Chojnacki C, Kaarniranta K. Zinc and Autophagy in Age-Related Macular Degeneration. Int J Mol Sci. 2020 Jul 15;21(14):4994. Benjamin P. Nicholson, et al. Chapter 37 - Zinc Deficiency and the Eye. Handbook of Nutrition, Diet and the Eye 2014, Pages 371-376.

In both children and adults, vitamin E deficiency can contribute to retinopathy and visual impairment because α‑tocopherol serves as a key fat‑soluble antioxidant that protects photoreceptor cells and retinal membranes from cumulative oxidative damage. Clinical reports describe patients with prolonged low vitamin E status developing pigmentary retinopathy, reduced visual acuity, and abnormal electroretinograms, sometimes alongside peripheral neuropathy, which can improve partially when deficiency is identified and corrected. These neurosensory changes appear more frequently in settings of fat malabsorption or genetic disorders affecting vitamin E transport, highlighting the importance of monitoring vitamin E status in at‑risk groups with otherwise unexplained visual decline.

Research: Runge P, Muller DP, McAllister J, Calver D, Lloyd JK, Taylor D. Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia. Br J Ophthalmol. 1986 Mar;70(3):166-73. Pang J, Kiyosawa M, Seko Y, Yokota T, Harino S, Suzuki J. Clinicopathological report of retinitis pigmentosa with vitamin E deficiency caused by mutation of the alpha-tocopherol transfer protein gene. Jpn J Ophthalmol. 2001 Nov-Dec;45(6):672-6. Edwards G, Olson CG, Euritt CP, Koulen P. Molecular Mechanisms Underlying the Therapeutic Role of Vitamin E in Age-Related Macular Degeneration. Front Neurosci. 2022 May 4;16:890021. Ng EY, Chiew Y, Phang SCW, Ng YT, Tan GCJ, et al. (2021) The Effects of Vitamin E on Non-proliferative Diabetic Retinopathy in Type 2 Diabetes Mellitus. Int J Diabetes Clin Res 8:142.

In some adults, significant thiamine (vitamin B1) deficiency can drive a hypermetabolic, vasodilated state with lactic acidosis, tachycardia, warm edema, and high‑output heart failure rather than the “typical” low‑output picture. Clinically, this pattern—often referred to as wet beriberi—can progress over days to weeks from exertional dyspnea and bounding pulses to hypotension and overt cardiovascular collapse if thiamine is not repleted. The encouraging part is that, when recognized in time, aggressive intravenous thiamine supplementation can produce striking hemodynamic improvement within hours, underscoring how crucial it is to maintain adequate ongoing thiamine intake in at‑risk patients.

Research: Hayek A, Djabou M, Mewton N, Bonnefoy-Cudraz E, Bochaton T. Thiamine Deficiency as a Cause for Acute Circulatory Failure: An Overlooked Association in Western Countries. CJC Open. 2020 Jul 19;2(6):716-718. Blanc P, Henriette K, Boussuges A. Severe metabolic acidosis and heart failure due to thiamine deficiency. Nutrition. 2002 Jan;18(1):118. Durstenfeld MS, Hsue PY. An Unusual, Reversible Cause of Acute High-Output Heart Failure Complicated by Refractory Shock. Circulation. 2020 Sep;142(9):901-905.Alamro Y, Arshad K, Latif R, Al Akeel M, Mozaffari MA. From Collapse to Recovery: Thiamine Intervention in Cardiac Beriberi. Cureus. 2024 Feb 14;16(2):e54179.

In adults with prolonged thiamine (vitamin B1) deficiency, an axonal polyneuropathy can develop that causes distal weakness, areflexia, and sensory loss that is typically more pronounced in the lower than the upper limbs. Clinicians often describe this “dry beriberi” neuropathy as starting with burning paresthesias and numbness in the feet, then ascending proximally over weeks to months as motor involvement and gait impairment emerge. The hopeful aspect is that timely and adequate thiamine repletion can halt progression and partially reverse neurologic deficits, especially when treatment begins before severe axonal loss and muscle wasting are established.

Research: Nisar S, Yousuf Wani I, Altaf U, Muzaffer U, Kareem O, Tanvir M, Ganie MA. Thiamine deficiency-related neuropathy: A reversible entity from an endemic area. Eur J Neurol. 2024 Mar;31(3):e16155. Shible AA, Ramadurai D, Gergen D, Reynolds PM. Dry Beriberi Due to Thiamine Deficiency Associated with Peripheral Neuropathy and Wernicke's Encephalopathy Mimicking Guillain-Barré syndrome: A Case Report and Review of the Literature. Am J Case Rep. 2019 Mar 13;20:330-334. Hamel JI, Logigian EL. Clinical Spectrum and Prognosis in Patients With Acute Nutritional Axonal Neuropathy. Neurology. 2023 May 16;100(20):e2134-e2140. Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum (Minneap Minn). 2014 Oct;20(5 Peripheral Nervous System Disorders):1293-306.

Impacted through 2 nutrients: Folic Acid, Zinc.

In pregnancy, inadequate folate status not only increases neural tube defect risk but is also associated with maternal megaloblastic anemia, which can worsen fatigue, reduce exercise tolerance, and increase the likelihood of transfusion around delivery. Observational studies have linked low folate and elevated homocysteine with a higher risk of miscarriage, placental complications, and low birth weight, and some data suggest that suboptimal folate status may contribute to certain infertility contexts, particularly when combined with other nutritional or metabolic stressors. The clinical takeaway is that maintaining sufficient folate intake before conception and throughout pregnancy is a key strategy to reduce anemia and support healthier fertility and pregnancy outcomes beyond neural tube defect prevention.

Research: Murto, T. et al. Folic acid supplementation and IVF pregnancy outcome in women with unexplained infertility. Dey M, Dhume P, Sharma SK, Goel S, Chawla S, Shah A, Madhumidha G, Rawal R. Folic acid: The key to a healthy pregnancy - A prospective study on fetomaternal outcome. Tzu Chi Med J. 2023 Oct 31;36(1):98-102. Hariz A, Bhattacharya PT. Megaloblastic Anemia. [Updated 2023 Apr 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan. Lazar VMA, Rahman S, Chowdhury NH, Hasan T, Akter S, Islam MS, Ahmed S, Baqui AH, Khanam R. Folate deficiency in pregnancy and the risk of preterm birth: A nested case-control study. J Glob Health. 2024 Jul 12;14:04120. Zheng J-S, Guan Y, Zhao Y, et al. Pre-conceptional intake of folic acid supplements is inversely associated with risk of preterm birth and small-for-gestational-age birth: a prospective cohort study. British Journal of Nutrition. 2016;115(3):509-516. Reproductive BioMedicine Online, Volume 28, Issue 6, 766 - 772

Closely linked to reproductive and hormonal problems in both men and women, zinc deficiency can contribute to hypogonadism, low testosterone, reduced sperm count, and menstrual irregularities. In men, low zinc status has been associated with decreased serum testosterone, reduced sperm density and motility, and poorer overall semen quality, while zinc repletion in deficient individuals has been shown to improve some of these parameters. In women, inadequate zinc intake is tied to more frequent cycle disturbances, dysmenorrhea, and potential impacts on ovulation and fertility, underscoring zinc’s important role in healthy hormonal balance and reproductive function.

Research: Zhao J, Dong X, Hu X, Long Z, Wang L, Liu Q, Sun B, Wang Q, Wu Q, Li L. Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis. Sci Rep. 2016 Mar 2;6:22386. Mohan H, Verma J, Singh I, Mohan P, Marwah S, Singh P. Inter-relationship of zinc levels in serum and semen in oligospermic infertile patients and fertile males. Indian J Pathol Microbiol. 1997 Oct;40(4):451-5. PMID: 9444854. Zečević N, Veselinović A, Perović M, Stojsavljević A. Association Between Zinc Levels and the Impact of Its Deficiency on Idiopathic Male Infertility: An Up-to-Date Review. Antioxidants (Basel). 2025 Jan 29;14(2):165. Dhar S, Yadav R, Tomar A. Serum Zinc Levels in Women with Polycystic Ovarian Syndrome are Lower as Compared to Those without Polycystic Ovarian Syndrome: A Cohort Study. J Hum Reprod Sci. 2024 Jan-Mar;17(1):25-32.

Thiamine (vitamin B1) deficiency can quietly undermine attention, memory, and executive function because several thiamine‑dependent enzymes are essential for the brain’s energy production and for healthy cholinergic signaling. Human studies have shown marked neuron loss in the mediodorsal thalamus and hippocampal atrophy in severe deficiency states, and the degree of this structural damage tracks closely with how impaired a person is on memory and other cognitive tests. Thiamine is also required for the biosynthesis of acetylcholine, a neurotransmitter crucial for learning and memory, so reduced cholinergic input to the hippocampus and frontal cortex further amplifies attention and memory problems when deficiency is prolonged.

Research: Behura SS, Swain SP. Neuropsychological functioning in Wernicke's encephalopathy. Ind Psychiatry J. 2015 Jan-Jun;24(1):99-103. Batarfi MA. Thiamine Deficiency and Brain Injury: Neuroanatomical Changes in the Wernicke-Korsakoff Syndrome. Cureus. 2025 Sep 18;17(9):e92643.Gibson GE, Hirsch JA, Fonzetti P, Jordan BD, Cirio RT, Elder J. Vitamin B1 (thiamine) and dementia. Ann N Y Acad Sci. 2016 Mar;1367(1):21-30. Teixeira J, Pereira I, Castanho M, Simões do Couto F. What is the impact of thiamine deficiency on cognitive function in patients with alcohol use disorder? - A systematic review. Eur J Intern Med. 2025 Apr;134:59-65.

The pancreas normally concentrates thiamine (vitamin B1) and tightly regulates its uptake, reflecting how important this vitamin is for insulin synthesis and secretion. Experimental studies in animals and islet models show that thiamine deficiency markedly impairs glucose oxidation and insulin release, while human data consistently find that people with diabetes tend to have significantly lower thiamine levels and higher urinary thiamine losses than those without diabetes. Taken together, these findings suggest that low thiamine status may worsen glycemic control and increase susceptibility to hyperglycemia by limiting insulin production and secretion.

Research: Alaei Shahmiri F, Soares MJ, Zhao Y, Sherriff J. High-dose thiamine supplementation improves glucose tolerance in hyperglycemic individuals: a randomized, double-blind cross-over trial. Eur J Nutr. 2013 Oct;52(7):1821-4. Luong KV, Nguyen LT. The impact of thiamine treatment in the diabetes mellitus. J Clin Med Res. 2012 Jun;4(3):153-60. Luong KV, Nguyen LT. The impact of thiamine treatment in the diabetes mellitus. J Clin Med Res. 2012 Jun;4(3):153-60. Ziegler D, Reiners K, Strom A, Obeid R. Association between diabetes and thiamine status - A systematic review and meta-analysis. Metabolism. 2023 Jul;144:155565.

Folate deficiency has been associated with a higher risk of depressive symptoms, irritability, and other mood disturbances, likely through its role in one‑carbon metabolism, monoamine neurotransmitter synthesis, and methylation processes in the brain. Clinical and epidemiologic studies have found that people with low folate or elevated homocysteine are more likely to experience major depression, and lower folate status has been linked to poorer response to certain antidepressant medications. The encouraging clinical point is that, in folate‑deficient individuals, correcting folate status (often with folic acid or methylfolate, and alongside vitamin B12 when indicated) may improve mood symptoms and, in some cases, enhance antidepressant treatment response, especially when combined with comprehensive psychiatric and lifestyle interventions.

Research: David Mischoulon, Maurizio Fava. Folate in Depression: Efficacy, Safety, Differences in Formulations, and Clinical Issues. The Journal of Clinical Psychiatry. 2009. Gao S, Khalid A, Amini-Salehi E, Radkhah N, Jamilian P, Badpeyma M, Zarezadeh M. Folate supplementation as a beneficial add-on treatment in relieving depressive symptoms: A meta-analysis of meta-analyses. Food Sci Nutr. 2024 Mar 8;12(6):3806-3818. Reynolds EH, Crellin R, Bottiglieri T, Laundy M, Toone BK, et al. Methylfolate as Monotherapy in Depression. A Pilot Randomised Controlled Trial. J Neurol Psychol. 2015;3(1): 5. Reynolds EH. Folic acid, ageing, depression, and dementia. BMJ. 2002 Jun 22;324(7352):1512-5. Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health. 2007 Jul;61(7):631-7.

Impacted through 2 nutrients: Zinc, Vitamin E.

Zinc deficiency during childhood and adolescence is strongly linked to impaired linear growth and delayed sexual maturation, and is a recognized contributor to stunting in many low‑ and middle‑income countries. In some population studies, zinc deficiency has been present in over 30–40% of children, and zinc supplementation programs have been associated with modest but meaningful improvements in height gain over time. Clinically, even marginal zinc deficiency can quietly slow growth velocity and pubertal progression, making adequate zinc intake an important, often overlooked pillar of healthy growth and development.

Research: Abdollahi M, Ajami M, Abdollahi Z, Kalantari N, Houshiarrad A, Fozouni F, Fallahrokni A, Mazandarani FS. Zinc supplementation is an effective and feasible strategy to prevent growth retardation in 6 to 24 month children: A pragmatic double blind, randomized trial. Heliyon. 2019 Nov 1;5(11):e02581. Walravens PA, Krebs NF, Hambidge KM. Linear growth of low income preschool children receiving a zinc supplement. Am J Clin Nutr. 1983 Aug;38(2):195-201. Rerksuppaphol S, Rerksuppaphol L. Zinc supplementation enhances linear growth in school-aged children: A randomized controlled trial. Pediatr Rep. 2018 Jan 4;9(4):7294. Zinc deficiency as risk factor for stunting among children aged 2-5 years. (2017). Universa Medicina, 36(1), 11-18.

Vitamin E deficiency can drive a progressive neurologic syndrome, including ataxia, sensory neuropathy, and myelopathy, because α‑tocopherol is a critical fat‑soluble antioxidant that protects neuronal membranes and prevents peroxidation of polyunsaturated fatty acids under oxidative stress. In both children with chronic cholestatic liver disease and adults without obvious fat malabsorption, low vitamin E status has been linked to characteristic large‑fiber sensory axonopathy and other degenerative changes, illustrating that unrecognized deficiency can present with strikingly “neurologic‑first” symptoms. When vitamin E deficiency is identified early, appropriately dosed, bioavailable α‑tocopherol supplementation can stabilize or partially reverse neurologic findings in some patients, underscoring the importance of screening at‑risk groups and not dismissing isolated ataxia or neuropathy as purely genetic or idiopathic.

Research: Sokol RJ, Butler-Simon N, Conner C, Heubi JE, Sinatra FR, Suchy FJ, Heyman MB, Perrault J, Rothbaum RJ, Levy J, et al. Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology. 1993 Jun;104(6):1727-35. Bonello M, Ray P. A Case of Ataxia with Isolated Vitamin E Deficiency Initially Diagnosed as Friedreich's Ataxia. Case Rep Neurol Med. 2016;2016:8342653. Agarwal A, Garg D, Srivastava AK. Ataxia with Vitamin E Deficiency: A Never to be Missed Treatable Ataxia. Ann Indian Acad Neurol. 2023 Nov-Dec;26(6):1011-1012. Chan KH, O'Sullivan M, Farouji I, Are G, Slim J. Sensory Axonopathy Associated With Vitamin E Deficiency. Cureus. 2021 Feb 17;13(2):e13389.

Vitamin E deficiency can present as a predominantly neuromuscular picture, in which slowly progressive peripheral neuropathy (often large‑fiber, length‑dependent, and sensory‑predominant) coexists with proximal muscle weakness and myopathy due to ongoing oxidative damage to peripheral nerves and muscle cell membranes. In reported series, patients have developed areflexia, gait instability, distal numbness, and reduced vibration sense along with elevated creatine kinase or myopathic changes on EMG, sometimes after years of unrecognized low vitamin E status rather than an obvious malabsorption syndrome. When deficiency is documented and α‑tocopherol is repleted with an adequately absorbed preparation, some individuals show meaningful improvements in strength, sensory symptoms, and electrophysiologic measures, highlighting that peripheral neuropathy and myopathy attributed to “idiopathic” or purely degenerative causes may in fact be partially reversible when vitamin E deficiency is identified and treated.

Research: Puri, V., Chaudhry, N., Tatke, M. and Prakash, V. (2005), Isolated vitamin E deficiency with demyelinating neuropathy. Muscle Nerve, 32: 230-235. Martinello F, Fardin P, Ottina M, Ricchieri GL, Koenig M, Cavalier L, Trevisan CP. Supplemental therapy in isolated vitamin E deficiency improves the peripheral neuropathy and prevents the progression of ataxia. J Neurol Sci. 1998 Apr 1;156(2):177-9. Hegele RA, Angel A. Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy. Can Med Assoc J. 1985 Jan 1;132(1):41-4. Sokol RJ, Butler-Simon N, Heubi JE, Iannaccone ST, McClung HJ, Accurso F, Hammond K, Heyman M, Sinatra F, Riely C, et al. Vitamin E deficiency neuropathy in children with fat malabsorption. Studies in cystic fibrosis and chronic cholestasis. Ann N Y Acad Sci. 1989;570:156-69.

In high‑risk settings such as prematurity or chronic fat malabsorption, vitamin E deficiency can contribute to hemolytic anemia because α‑tocopherol is a fat‑soluble antioxidant that keeps red blood cell membranes more stable under everyday oxidative stress. By helping prevent damage to the polyunsaturated fatty acids in these membranes, vitamin E lowers the chance that red blood cells will break apart too early, which can otherwise show up as fatigue, pallor, jaundice, and lab evidence of anemia. In very low birth‑weight infants and in people with long‑standing fat‑absorption problems, spotting low vitamin E levels early and using a well‑absorbed natural Vitamin E supplement can meaningfully reduce hemolysis risk and support healthier hemoglobin levels over time.

Research: Jilani T, Iqbal MP. Does vitamin E have a role in treatment and prevention of anemia? Pak J Pharm Sci. 2011 Apr;24(2):237-42. Gomez-Pomar E, Hatfield E, Garlitz K, Westgate PM, Bada HS. Vitamin E in the Preterm Infant: A Forgotten Cause of Hemolytic Anemia. Am J Perinatol. 2018 Feb;35(3):305-310. Gross, S., Landaw, S. & Oski, F. The effects of vitamin E on hemolysis in premature infants during the first week of life. Pediatr Res 11, 472 (1977).Jilani T, Iqbal MP. Vitamin E deficiency in South Asian population and the therapeutic use of alpha-tocopherol (Vitamin E) for correction of anemia. Pak J Med Sci. 2018 Nov-Dec;34(6):1571-1575.

In both inherited and acquired deficiency states, vitamin E deficiency can contribute to cerebellar dysfunction and central cognitive effects because α‑tocopherol protects vulnerable neurons, including cerebellar Purkinje cells, from ongoing oxidative damage across the lifespan. In AVED, where an α‑TTP defect prevents normal vitamin E transport, deficiency is associated with spinocerebellar ataxia, Purkinje cell loss, degeneration of sensory neurons, and a characteristic “dying back” neuropathy, yet long‑term α‑tocopherol supplementation over many years can slow or even prevent further neurologic progression when started early. Experimental and clinical data also show that even brief interruptions in vitamin E supplementation can measurably lower plasma total radical‑trapping antioxidant capacity before obvious symptom worsening, highlighting renewed oxidative vulnerability of nervous tissue and reinforcing the importance of consistent repletion to support normal neurogenesis and central nervous system function.

Research: Thapa S, Shah S, Chand S, Sah SK, Gyawali P, Paudel S, Khanal P. Ataxia due to vitamin E deficiency: A case report and updated review. Clin Case Rep. 2022 Sep 6;10(9):e6303. Schuelke M, Finckh B, Sistermans EA, Ausems MG, Hübner C, von Moers A. Ataxia with vitamin E deficiency: biochemical effects of malcompliance with vitamin E therapy. Neurology. 2000 Nov 28;55(10):1584-6. N. Stojiljkovic, S. Redko, F. Gupta, S. Kathiresu Nageshwaran, W. Tse. Cerebellar ataxia due to vitamin E deficiency [abstract]. Mov Disord. 2023; 38 (suppl 1). Traber MG. Vitamin E: necessary nutrient for neural development and cognitive function. Proc Nutr Soc. 2021 Aug;80(3):319-326.

In very sick adults, low thiamine (vitamin B1) can quietly help drive lactic acidosis because the body cannot properly use sugar for energy without it. When thiamine is missing, pyruvate “backs up” and is turned into lactate instead of entering the energy‑producing cycle in the mitochondria, so people with sepsis, heart failure, or shock can develop higher or more persistent lactate levels than their blood flow problems alone would explain. The practical point is that, when lactate stays stubbornly high for no clear reason, giving thiamine is a simple, low‑risk step that can sometimes lead to a surprisingly fast drop in lactate and a visible clinical improvement.

Research: Amrein K, Ribitsch W, Otto R, Worm HC, Stauber RE. Severe lactic acidosis reversed by thiamine within 24 hours. Crit Care. 2011;15(6):457. Hong J, Cho D, Kim HJ, Jo J, Seong GM. Reversible Severe Acute Lactic Acidosis Caused by Thiamine Deficiency in Intensive Care Unit. Case Rep Crit Care. 2025 May 8;2025:3211626. Lerner RK, Pessach I, Rubinstein M, Paret G. Lactic Acidosis as Presenting Symptom of Thiamine Deficiency in Children with Hematologic Malignancy. J Pediatr Intensive Care. 2017 Jun;6(2):132-135. Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, Chou PP, Ngo L. Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010 Dec;25(4):576-81.

Folate (folic acid) deficiency impairs DNA synthesis in rapidly dividing cells, which leads to megaloblastic anemia characterized by enlarged red blood cells, fatigue, pallor, and sometimes shortness of breath. Population studies have shown that folate deficiency and macrocytosis can be present for months before overt symptoms appear, and in some cohorts, up to roughly one quarter of anemic adults had an underlying folate or B12 deficiency rather than iron deficiency alone. The encouraging clinical point is that, once identified, folate‑responsive megaloblastic anemia often improves within weeks of adequate folic acid repletion, with reticulocyte counts rising in about 5–7 days and hemoglobin recovering more gradually over several weeks.

Research: Koury MJ, Price JO, Hicks GG. Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism. Blood. 2000 Nov 1;96(9):3249-55. Daniel S. Socha, MD, Sherwin I. DeSouza, MD, Aron Flagg, MD, Mikkael Sekeres, MD, MS and Heesun J. Rogers, MD, PhD. Severe megaloblastic anemia: Vitamin deficiency and other causes. Cleveland Clinic Journal of Medicine March 2020, 87 (3) 153-164. H.B. Castellanos-Sinco, et al. Megaloblastic anaemia: Folic acid and vitamin B12 metabolism. Revista Médica del Hospital General de México. Vol. 78. Issue 3. Pages 105-150 (July - September 2015). Anis Hariz, et al. Megaloblastic Anemia. StatPearls April 3, 2023.

Zinc deficiency often first shows up on the skin, with acrodermatitis‑like eruptions around the mouth, perineum, and distal extremities, accompanied by alopecia and sometimes nail changes. Characteristic lesions can be erythematous, scaly, or pustular, and both congenital and acquired zinc deficiency states have been reported to improve dramatically within days to weeks of adequate zinc repletion. Clinically, zinc is also crucial for normal collagen synthesis and immune function in the skin, so deficiency is linked to delayed wound healing and weaker scars, whereas restoring zinc status can enhance re‑epithelialization and reduce wound complications.

Research: Kelly S, Stelzer JW, Esplin N, Farooq A, Karasik O. Acquired Acrodermatitis Enteropathica: A Case Study. Cureus. 2017 Sep 8;9(9):e1667. Alwadany MM, Al Wadani AF, Almarri FH, Alyami HS, Al-Subaie MA. Acrodermatitis Enteropathica: A Rare Case With Lifelong Implications. Cureus. 2023 Apr 18;15(4):e37783. Al-Khafaji Z, Brito S, Bin BH. Zinc and Zinc Transporters in Dermatology. Int J Mol Sci. 2022 Dec 18;23(24):16165. Ogawa Y, Kinoshita M, Shimada S, Kawamura T. Zinc and Skin Disorders. Nutrients. 2018 Feb 11;10(2):199.

In some adults, thiamine (vitamin B1) deficiency shows up first in the gut, with anorexia, nausea, early satiety, abdominal discomfort, constipation, or a sense that “the stomach and intestines just are not moving right.” Case reports and small series in humans describe improvement in nausea, constipation, dysphagia, and intestinal dysmotility after thiamine supplementation, which supports a causal role for deficiency in disordered gastrointestinal motor and secretory function. The practical takeaway is that, when patients have otherwise unexplained appetite loss and upper or lower GI symptoms in the setting of poor intake, alcohol use, or critical illness, it is important to consider and correct possible thiamine deficiency as part of the evaluation.

Research: Prakash S. Gastrointestinal beriberi: a forme fruste of Wernicke's encephalopathy? BMJ Case Rep. 2018 Jul 6;2018:bcr2018224841. Duca J, Lum C. Rare Presentation of Thiamine Deficiency as Gastrointestinal Syndrome. Hawaii J Med Public Health. 2014 Sep;73(9 Suppl 1):46. PMCID: PMC4175961. Overton E, Emelyanova A, Bunik VI. Thiamine, gastrointestinal beriberi and acetylcholine signaling. Front Nutr. 2025 Apr 9;12:1541054. A. Meckley et al. Suspected Thiamine Deficiency Secondary to Chronic. HCA Healthcare Journal of Medicine (2024) 5:2 Gastrointestinal Illness: A Case Report.

In many patients, inadequate zinc status affects the gastrointestinal tract, contributing to chronic or recurrent diarrhea, anorexia, and characteristic changes in taste (hypogeusia) and smell (hyposmia) that further suppress intake. Clinical studies in children with acute and persistent diarrhea have shown that zinc supplementation shortens illness duration and reduces subsequent diarrheal episodes, underscoring how low zinc status both results from and perpetuates gut losses. The practical implication is that, when patients present with otherwise unexplained diarrhea, poor appetite, and altered taste or smell, especially in the setting of malabsorption, restrictive diets, or chronic illness, evaluating and correcting zinc deficiency can be an important step in breaking this cycle and restoring nutritional and gastrointestinal health.

Research: Mozaffar B, Ardavani A, Muzafar H, Idris I. The Effectiveness of Zinc Supplementation in Taste Disorder Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Nutr Metab. 2023 Mar 8;2023:6711071. Heckmann SM, Hujoel P, Habiger S, Friess W, Wichmann M, Heckmann JG, Hummel T. Zinc gluconate in the treatment of dysgeusia--a randomized clinical trial. J Dent Res. 2005 Jan;84(1):35-8. Mahajan SK, Prasad AS, Lambujon J, Abbasi AA, Briggs WA, McDonald FD. Improvement of uremic hypogeusia by zinc: a double-blind study. Am J Clin Nutr. 1980 Jul;33(7):1517-21. Aliani M, Udenigwe CC, Girgih AT, Pownall TL, Bugera JL, Eskin MN. Zinc deficiency and taste perception in the elderly. Crit Rev Food Sci Nutr. 2013;53(3):245-50. Tanaka H, Mori E, Yonezawa N, Sekine R, Nagai M, Tei M, Otori N. Efficacy of Normalising Serum Zinc Level for Patients with Olfactory Dysfunction and Zinc Deficiency. ORL J Otorhinolaryngol Relat Spec. 2024;86(2):73-81.

In fat‑malabsorption states and cholestatic liver disease, vitamin E deficiency can amplify oxidative injury because α‑tocopherol is normally carried on circulating lipoproteins and helps shield both cell membranes and lipids from ongoing free‑radical damage. In severe genetic fat‑malabsorption such as abetalipoproteinemia, very low plasma vitamin E levels have been linked to progressive ophthalmopathy and neuropathy, and even with aggressive supplementation, HDL particles can remain severely oxidized, signaling persistent lipid peroxidation and oxidative modification of lipoproteins. Together, these observations support the idea that vitamin E deficiency layered on top of structurally abnormal or depleted lipoproteins creates a “perfect storm” for heightened oxidative stress in tissues, underscoring the need for early detection, carefully absorbed α‑tocopherol formulations, and close monitoring of at‑risk patients with chronic cholestasis or malabsorption.

Research: Burnett JR, Hooper AJ. Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia. Free Radic Biol Med. 2015 Nov;88(Pt A):59-62. Siener R, Machaka I, Alteheld B, Bitterlich N, Metzner C. Effect of Fat-Soluble Vitamins A, D, E and K on Vitamin Status and Metabolic Profile in Patients with Fat Malabsorption with and without Urolithiasis. Nutrients. 2020 Oct 12;12(10):3110. Margareth L. G. SaronI, et al. Nutritional status of patients with biliary atresia and autoimmune hepatitis related to serum levels of vitamins A, D and E. Department of Pediatrics. UNICAMP, Campinas, SP, Brazil 2008. Granot E, Kohen R. Oxidative stress in abetalipoproteinemia patients receiving long-term vitamin E and vitamin A supplementation. Am J Clin Nutr. 2004 Feb;79(2):226-30.